John Hines

6.5k total citations · 2 hit papers
113 papers, 5.1k citations indexed

About

John Hines is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, John Hines has authored 113 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 20 papers in Genetics and 16 papers in Hematology. Recurrent topics in John Hines's work include Chronic Lymphocytic Leukemia Research (14 papers), Surfactants and Colloidal Systems (12 papers) and Folate and B Vitamins Research (12 papers). John Hines is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Surfactants and Colloidal Systems (12 papers) and Folate and B Vitamins Research (12 papers). John Hines collaborates with scholars based in United States, United Kingdom and Netherlands. John Hines's co-authors include R. Kanti, Robert K. Thomas, Bercedis L. Peterson, Laurence Elias, Richard A. Larson, Charles A. Schiffer, Lois E. Shepherd, Jonathan E. Kolitz, Frederick R. Appelbaum and David J. Adelstein and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

John Hines

111 papers receiving 4.7k citations

Hit Papers

Fludarabine Compared with Chlorambucil as Primary Therapy... 1998 2026 2007 2016 2000 1998 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Hines United States 37 1.5k 1.3k 1.2k 796 698 113 5.1k
Paul J. Schmidt United States 46 1.4k 1.0× 2.2k 1.6× 553 0.5× 754 0.9× 2.3k 3.3× 283 9.8k
D. Todd China 38 1.8k 1.3× 744 0.6× 1.0k 0.9× 986 1.2× 1.5k 2.2× 162 5.5k
James B. Mitchell United States 52 1.7k 1.1× 3.3k 2.5× 581 0.5× 1.6k 1.9× 170 0.2× 136 11.3k
Hirokazu Komatsu Japan 47 724 0.5× 2.0k 1.5× 1.2k 1.0× 1.5k 1.9× 807 1.2× 271 7.5k
Johan Malm Sweden 38 468 0.3× 1.3k 1.0× 432 0.4× 505 0.6× 733 1.1× 172 5.5k
James T. Cassidy United States 40 244 0.2× 1.6k 1.2× 822 0.7× 2.9k 3.6× 1.2k 1.7× 106 7.2k
Anthony Markham New Zealand 60 424 0.3× 2.3k 1.7× 729 0.6× 1.8k 2.2× 496 0.7× 163 9.3k
O. Michael Colvin United States 42 1.3k 0.9× 2.5k 1.9× 510 0.4× 1.9k 2.4× 1.8k 2.5× 124 7.0k
Michael Hayes United States 33 958 0.7× 1.2k 0.9× 270 0.2× 574 0.7× 1.2k 1.7× 97 4.1k
Sang‐Cheol Bae South Korea 59 1.3k 0.9× 2.1k 1.6× 1.8k 1.6× 1.6k 2.0× 1.8k 2.6× 501 16.5k

Countries citing papers authored by John Hines

Since Specialization
Citations

This map shows the geographic impact of John Hines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hines more than expected).

Fields of papers citing papers by John Hines

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hines. The network helps show where John Hines may publish in the future.

Co-authorship network of co-authors of John Hines

This figure shows the co-authorship network connecting the top 25 collaborators of John Hines. A scholar is included among the top collaborators of John Hines based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Hines. John Hines is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kenters, Nikki, et al.. (2020). Product dose considerations for real-world hand sanitiser efficacy. American Journal of Infection Control. 48(5). 503–506. 14 indexed citations
2.
Azim, Syed, C. Juergens, John Hines, & Mary‐Louise McLaws. (2016). Introducing automated hand hygiene surveillance to an Australian hospital: Mirroring the HOW2 Benchmark Study. American Journal of Infection Control. 44(7). 772–776. 19 indexed citations
3.
Walker, Abigail, John Hines, & John Brecknell. (2016). Survival of the Grittiest? Consultant Surgeons Are Significantly Grittier Than Their Junior Trainees. Journal of surgical education. 73(4). 730–734. 52 indexed citations
4.
Reisine, Terry, Donna S. Woulfe, K Raynor, et al.. (2007). Interaction of Somatostatin Receptors with G Proteins and Cellular Effector Systems. Novartis Foundation symposium. 190. 160–170. 6 indexed citations
5.
Dutcher, Janice P., Sandra Lee, Robert J. Gallagher, et al.. (2004). Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: A study of the Eastern Cooperative Oncology Group (E1993). Leukemia & lymphoma. 46(3). 377–385. 7 indexed citations
6.
Hu, Peng, John R. Moffett, Jason Myers, et al.. (2001). Novel Nuclear Signaling Pathway Mediates Activation of Fibroblast Growth Factor-2 Gene by Type 1 and Type 2 Angiotensin II Receptors. Molecular Biology of the Cell. 12(2). 449–462. 85 indexed citations
7.
Kanti, R., Bercedis L. Peterson, Frederick R. Appelbaum, et al.. (2000). Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia. New England Journal of Medicine. 343(24). 1750–1757. 754 indexed citations breakdown →
8.
Hines, John, Steven J. Fluharty, & Randall R. Sakai. (1999). The angiotensin AT1 receptor antagonist irbesartan has near-peptide affinity and potently blocks receptor signaling. European Journal of Pharmacology. 384(1). 81–89. 14 indexed citations
9.
Rennie, George, et al.. (1998). Skin irritation potential of mixed surfactant systems. Food and Chemical Toxicology. 36(3). 233–238. 70 indexed citations
10.
Yee, Daniel K., Xudong Yang, Lawrence P. Reagan, et al.. (1997). Cloning and expression of angiotensin II type 2 (AT2) receptors from murine neuroblastoma N1E-115 cells: evidence for AT2 receptor heterogeneity. Molecular Brain Research. 45(1). 108–116. 12 indexed citations
11.
Hines, John & Irving Nachamkin. (1996). Effective Use of the Clinical Microbiology Laboratory for Diagnosing Diarrheal Diseases. Clinical Infectious Diseases. 23(6). 1292–1301. 28 indexed citations
12.
Mazza, J. J., John Hines, Janet W. Andersen, et al.. (1995). Aggressive Chemotherapy in the Treatment of Burkitt's and Non-BurKitt's Undifferentiated Lymphoma. Leukemia & lymphoma. 18(3-4). 289–296. 5 indexed citations
13.
Adelstein, David J., et al.. (1991). Diffuse Well Differentiated Lymphocytic Lymphoma: A Clinical Study of 22 Patients. Oncology. 48(1). 48–53. 2 indexed citations
14.
Rowe, Jacob M., J. J. Mazza, John Hines, et al.. (1990). Mitoxantrone and Etoposide in Patients with Relapsed and Refractory Acute Nonlymphocytic Leukemia. Hämatologie und Bluttransfusion. 33. 326–329. 8 indexed citations
15.
Adelstein, David J., et al.. (1990). Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer. 65(8). 1685–1691. 89 indexed citations
16.
17.
Adelstein, David J., et al.. (1988). Multiple Myeloma Presenting with Spinal Cord Compression. Oncology. 45(2). 88–92. 21 indexed citations
18.
Hines, John, et al.. (1988). Treatment of advanced-stage colorectal adenocarcinoma with fluorouracil and high-dose leucovorin calcium: a pilot study.. Journal of Clinical Oncology. 6(1). 142–146. 24 indexed citations
19.
Adelstein, David J., et al.. (1986). Chemoradiotherapy as initial management in patients with squamous cell carcinoma of the head and neck.. PubMed. 70(6). 761–7. 12 indexed citations
20.
Bacon, Bruce R., et al.. (1984). Parietal Cell Function of Full‐Term and Premature Infants. Journal of Pediatric Gastroenterology and Nutrition. 3(1). 23–27.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026